CLINICAL_TRIALS
trial_result
· 2023-02-02
Clinical Trial Update: Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO) [Phase 1, Phase 2]
Summary
Phase 1/2 trial update on safety and tolerability of high-dose rifapentine with isoniazid for latent TB infection in HIV+ patients, compared to standard INH the…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Aurum Institute NPC | Conditions: Respiratory Tract Infections, HIV Infections | Phase 1, Phase 2 | Status: COMPLETED